Target intelligence / Profile preview

Cytochrome b subunit of the cytochrome bc1 complex (QcrB) (QcrB)

Target
QcrB
Molecular classification
Enzyme, Oxidoreductase, Transmembrane protein
01

Overview

The Cytochrome b subunit of the cytochrome bc1 complex (QcrB) is a vital component of the respiratory electron transport chain in Mycobacterium tuberculosis (UniProt: P9WNJ5). It functions as a transmembrane protein that facilitates the transfer of electrons from ubiquinol to cytochrome c1, a process coupled with proton translocation across the cytoplasmic membrane to generate a proton motive force (PubMed: 23913081). This electrochemical gradient is essential for ATP synthesis via ATP synthase, providing the energy required for bacterial growth and survival (PubMed: 30670640). In the context of disease, QcrB is a validated therapeutic target for treating multidrug-resistant and extensively drug-resistant tuberculosis (Nature Medicine, 2013). Small molecules such as Telacebec (Q203) and TB47 bind to the Qp site of the QcrB subunit, effectively halting cellular respiration and leading to bacterial death (PubMed: 30670640). However, the clinical utility of QcrB inhibitors can be challenged by the emergence of spontaneous mutations in the qcrB gene and the presence of alternative respiratory pathways, such as the cytochrome bd oxidase, which can partially bypass the bc1 complex (PubMed: 33432151).

Other names
Cytochrome bUbiquinol-cytochrome c reductase subunit bComplex III subunit bMTCY27G12.23
02

Mechanism of action

Inhibition of the ubiquinol-binding (Qp) site of the cytochrome bc1 complex, blocking electron transfer and ATP production.

03

Biological functions

Electron transport chainOxidative phosphorylationATP synthesisProton translocation
04

Disease associations

Infection
05

Safety considerations

Emergence of drug resistance via qcrB mutationsMetabolic bypass via cytochrome bd oxidasePotential for drug-drug interactions
06

Interacting drugs

Telacebec (Q203)

3 more in the full profile.

07

Biomarkers

Sputum culture conversion (SCC)Time to detection (TTD) in liquid cultureqcrB gene mutations (resistance monitoring)

Beyond the preview

Go deeper on Cytochrome b subunit of the cytochrome bc1 complex (QcrB) (QcrB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome b subunit of the cytochrome bc1 complex (QcrB) (QcrB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call